Results 221 to 230 of about 492,788 (273)

Notification that new names of prokaryotes, new combinations, and new taxonomic opinions have appeared in volume 74, part 1 of the IJSEM. [PDF]

Int J Syst Evol Microbiol
Oren A, Göker M.
europepmc   +1 more source

Sherborn's Index Animalium: New names, systematic errors and availability of names in the light of modern nomenclature. [PDF]

Zookeys, 2016
Welter-Schultes F, Görlich A, Lutze A.
europepmc   +1 more source

Tumor mutational burden as a determinant of metastatic dissemination patterns

Molecular Oncology, EarlyView.
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal, Andrea Moreno‐Manuel, Miguel Salvadó‐Pertierra, Cristina Santos‐Vivas, Rebeca Sanz‐Pamplona   +4 more
wiley   +1 more source

Notification that new names of prokaryotes, new combinations, and new taxonomic opinions have appeared in volume 73, part 12 of the IJSEM. [PDF]

Int J Syst Evol Microbiol
Oren A, Göker M.
europepmc   +1 more source

Notification that new names of prokaryotes, new combinations, and new taxonomic opinions have appeared in volume 67, part 8, of the IJSEM. [PDF]

Int J Syst Evol Microbiol, 2017
Oren A, Garrity GM.
europepmc   +1 more source

Hathoronthophagus, new replacement name for Hathor Deschodt, 2023, preoccupied genus-group name of a putatively myrmecophilic dung beetle (Scarabaeidae: Scarabaeinae: Onthophagini)

Riaan Stals, Gimo M. Daniel, CHRISTIAN M. DESCHODT   +2 more
openalex   +2 more sources

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source

Notification that new names of prokaryotes, new combinations, and new taxonomic opinions have appeared in volume 73, part 11 of the IJSEM. [PDF]

Int J Syst Evol Microbiol
Oren A, Göker M.
europepmc   +1 more source

Notification that new names of prokaryotes, new combinations, and new taxonomic opinions have appeared in volume 67, part 7, of the IJSEM. [PDF]

Int J Syst Evol Microbiol, 2017
Oren A, Garrity GM.
europepmc   +1 more source